Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing.
Blackwell
N
N
Hayllar
J
J
Kelly
G
G
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D006801:Humans; D008297:Male; D020888:Vigabatrin; D014786:Vision Disorders / Q000139:chemically induced; D014787:Vision Tests; D014794:Visual Fields; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin